(Q44869224)

English

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease

scientific article published on 6 November 2012

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Extensive bone marrow infiltration and abnormal free light chain ratio identifies patients with asymptomatic myeloma at high risk for progression to symptomatic disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Efstathios Kastritis

1

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

Athanasios Dimopoulos

12

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Spyropoulou-Vlachou

4

object named as

M Spyropoulou-Vlachou

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

E Eleftherakis-Papaiakovou

6

object named as

E Eleftherakis-Papaiakovou

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

author name string

E Terpos

2

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

L Moulopoulos

3

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

N Kanellias

5

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Gkotzamanidou

7

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Migkou

8

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Gavriatopoulou

9

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

M Roussou

10

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

A Tasidou

11

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

publication date

6 November 2012

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

4

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

947-953

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

https://scigraph.springernature.com/pub.10.1038/leu.2012.309

0 references

Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Smoldering (asymptomatic) multiple myeloma: current diagnostic criteria, new predictors of outcome, and follow-up recommendations

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Immunoglobulin free light chain ratio is an independent risk factor for progression of smoldering (asymptomatic) multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

New criteria to identify risk of progression in monoclonal gammopathy of uncertain significance and smoldering multiple myeloma based on multiparameter flow cytometry analysis of bone marrow plasma cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Diffuse pattern of bone marrow involvement on magnetic resonance imaging is associated with high risk cytogenetics and poor outcome in newly diagnosed, symptomatic patients with multiple myeloma: a single center experience on 228 patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

A multicenter, randomized clinical trial comparing zoledronic acid versus observation in patients with asymptomatic myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Combined evaluation of bone marrow aspirate and biopsy is superior in the prognosis of multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Diagnosis of smoldering multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Pamidronate versus observation in asymptomatic myeloma: final results with long-term follow-up of a randomized study

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Prognostic relevance of 18-F FDG PET/CT in newly diagnosed multiple myeloma patients treated with up-front autologous transplantation.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

A prospective comparison of 18F-fluorodeoxyglucose positron emission tomography-computed tomography, magnetic resonance imaging and whole-body planar radiographs in the assessment of bone disease in newly diagnosed multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Smoldering multiple myeloma: natural history and recognition of an evolving type

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Clinical Course and Prognosis of Smoldering (Asymptomatic) Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Diffuse MRI marrow pattern correlates with increased angiogenesis, advanced disease features and poor prognosis in newly diagnosed myeloma treated with novel agents

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

21 January 2018

Prognostic Significance of Focal Lesions in Whole-Body Magnetic Resonance Imaging in Patients With Asymptomatic Multiple Myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Prognostic significance of magnetic resonance imaging in patients with asymptomatic multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Estimation of failure probabilities in the presence of competing risks: new representations of old estimators

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Comparison of plasma cell infiltration in bone marrow biopsies and aspirates in patients with multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Bone marrow trephine combined with immunohistochemistry is superior to bone marrow aspirate in follow-up of myeloma patients

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2012.309

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1038/LEU.2012.309

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

7 December 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44869224&oldid=2054752858"